Director, Analytical Development

Our Culture: Why work with us?

At Foghorn Therapeutics, we believe in “People First, Mission Always.”

We put “People First” because we know our people are the key to everything we will accomplish. We value the diversity of background, ideas, perspectives and experiences that our team members bring to Foghorn Therapeutics – demonstrated by our community speaking more than 22 languages and representing over 24 nationalities. We value our teammates as people, not just as employees – validated by our actions that let our people know that we care about them, their families, and their lives.

We say “Mission Always” because we know a relentless commitment to our mission will make a difference in the lives of others. We believe our success will come from evaluating the data to follow the science. We work hard to develop a new class of therapies that could improve the lives of over 2.5 million people with cancer.

Our culture is focused on...

The Director, Analytical Development (AD) is responsible for setting strategy for the analytical development function and executing the strategy to meet all applicable regulatory guidance.  The Director will lead efforts to develop assays through transfer and validate assays for the characterization of viral vector biologics in support of the Company’s product development projects. This includes both internal as well as with external vendors and contractors.

About Ascend: 

Ascend is pioneering the future of healthcare through relentless innovation, our forward-thinking company is on a mission to manufacture safe, efficacious, and scalable gene therapies. Our vision is to set a new standard for gene therapy manufacturing through continuous scientific and process innovation. Our teams, rooted in biopharma, possess regulatory knowledge and prioritize the quality and potency of manufacturing high-class products.

Our goal is to inspire the...

Full-time

Location: London/UK/Europe (Office/Remote), Boston/US (Office/Remote)

Reporting to: VP Clinical Development

Job Summary

Orchard Therapeutics, recently acquired by Kyowa Kirin, is a global biotechnology gene therapy company dedicated to transforming the lives of people affected by rare diseases through the development of innovative, potentially curative gene therapies. Our ex vivo autologous gene therapy approach harnesses the power of genetically modified blood stem cells and seeks to correct the underlying cause of disease in a single administration. Orchard has its global headquarters in London and U.S. headquarters in Boston.

The Director, Bioanalytical Diagnostic Development, will be responsible for defining the global bioanalytical development strategy and leading all activities related to clinical bioassays/diagnostics, from preparations for ‘first in human’ up to...